129 related articles for article (PubMed ID: 19802572)
1. Autophagy in HIV-induced T cell death.
Espert L; Biard-Piechaczyk M
Curr Top Microbiol Immunol; 2009; 335():307-21. PubMed ID: 19802572
[TBL] [Abstract][Full Text] [Related]
2. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4.
Espert L; Denizot M; Grimaldi M; Robert-Hebmann V; Gay B; Varbanov M; Codogno P; Biard-Piechaczyk M
J Clin Invest; 2006 Aug; 116(8):2161-72. PubMed ID: 16886061
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of CD4 T-cell depletion triggered by HIV-1 viral proteins.
Varbanov M; Espert L; Biard-Piechaczyk M
AIDS Rev; 2006; 8(4):221-36. PubMed ID: 17219737
[TBL] [Abstract][Full Text] [Related]
4. What is the role of autophagy in HIV-1 infection?
Espert L; Codogno P; Biard-Piechaczyk M
Autophagy; 2008 Apr; 4(3):273-5. PubMed ID: 17993779
[TBL] [Abstract][Full Text] [Related]
5. Autophagy and CD4+ T lymphocyte destruction by HIV-1.
Espert L; Denizot M; Grimaldi M; Robert-Hebmann V; Gay B; Varbanov M; Codogno P; Biard-Piechaczyk M
Autophagy; 2007; 3(1):32-4. PubMed ID: 17012832
[TBL] [Abstract][Full Text] [Related]
6. Autophagy restricts HIV-1 infection by selectively degrading Tat in CD4+ T lymphocytes.
Sagnier S; Daussy CF; Borel S; Robert-Hebmann V; Faure M; Blanchet FP; Beaumelle B; Biard-Piechaczyk M; Espert L
J Virol; 2015 Jan; 89(1):615-25. PubMed ID: 25339774
[TBL] [Abstract][Full Text] [Related]
7. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
Carcelain G; Tubiana R; Samri A; Calvez V; Delaugerre C; Agut H; Katlama C; Autran B
J Virol; 2001 Jan; 75(1):234-41. PubMed ID: 11119593
[TBL] [Abstract][Full Text] [Related]
8. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
9. Modeling interleukin-2-based immunotherapy in AIDS pathogenesis.
Joly M; Odloak D
J Theor Biol; 2013 Oct; 335():57-78. PubMed ID: 23806696
[TBL] [Abstract][Full Text] [Related]
10. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.
Chen P; Hübner W; Spinelli MA; Chen BK
J Virol; 2007 Nov; 81(22):12582-95. PubMed ID: 17728240
[TBL] [Abstract][Full Text] [Related]
11. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
12. The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy.
Dyrhol-Riise AM; Stent G; Røsok BI; Voltersvik P; Olofsson J; Asjö B
Clin Immunol; 2001 Nov; 101(2):169-79. PubMed ID: 11683576
[TBL] [Abstract][Full Text] [Related]
13. Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAART.
Lorenzo E; Colon MC; Almodovar S; Maldonado IM; Gonzalez S; Costa SE; Hill MD; Mendoza R; Sepulveda G; Yanagihara R; Nerurkar V; Kumar R; Yamamura Y; Scott WA; Kumar A
Virology; 2004 Dec; 330(1):116-26. PubMed ID: 15527839
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
Molina L; Grimaldi M; Robert-Hebmann V; Espert L; Varbanov M; Devaux C; Granier C; Biard-Piechaczyk M
Proteomics; 2007 Sep; 7(17):3116-30. PubMed ID: 17676665
[TBL] [Abstract][Full Text] [Related]
15. Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.
Boyd DF; Peterson D; Haggarty BS; Jordan AP; Hogan MJ; Goo L; Hoxie JA; Overbaugh J
J Virol; 2015 Jan; 89(2):894-907. PubMed ID: 25378497
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Env induces pexophagy and an oxidative stress leading to uninfected CD4
Daussy CF; Galais M; Pradel B; Robert-Hebmann V; Sagnier S; Pattingre S; Biard-Piechaczyk M; Espert L
Autophagy; 2021 Sep; 17(9):2465-2474. PubMed ID: 33073673
[TBL] [Abstract][Full Text] [Related]
17. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
Herbeuval JP; Shearer GM
AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
[TBL] [Abstract][Full Text] [Related]
18. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
19. How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses?
Makvandi-Nejad S; Rowland-Jones S
Immunol Lett; 2015 Jan; 163(1):69-75. PubMed ID: 25445493
[TBL] [Abstract][Full Text] [Related]
20. [The expression of some homing and co-receptor molecules on CD4+ T cells in AIDS patients].
Tan Y; Zhang MX; Liu YX; Chen XC; Zhou BP; Wang H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):257-60. PubMed ID: 20108767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
